C09DA04 • irbesartan + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics
The combination of irbesartan and hydrochlorothiazide is used to treat essential hypertension in patients who do not respond adequately to monotherapy. Irbesartan is an angiotensin II receptor antagonist that helps relax blood vessels, while hydrochlorothiazide is a diuretic that reduces fluid volume in the body, thereby lowering blood pressure.
The medication is taken orally, usually once daily, as directed by a doctor.
Side effects may include dizziness, fatigue, nausea, or electrolyte imbalances. In rare cases, severe allergic reactions or kidney dysfunction may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.
Substance: irbesartan + hydrochlorothiazide
Date of last drug list: 01-07-2013
Commercial code: W51558004
Concentration: 300mg / 12.5mg
Pharmaceutical form: tablets
Quantity: 98
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.